Evidence map›Paper›PMID 29629278›Full record

ArticleKidney research and clinical practice2018

Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease.

Nam-Jun Cho, Chi-Young Choi, Samel Park, Sang-Ho Park, Eun Young Lee, Hyo-Wook Gil

Abstract read
In one paragraph

Article in Kidney research and clinical practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nam-Jun ChoDepartment of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Chi-Young ChoiDepartment of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Samel ParkDepartment of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Sang-Ho ParkDepartment of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Eun Young LeeDepartment of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Hyo-Wook GilDepartment of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies have suggested that proton pump inhibitor (PPI) use is associated with adverse renal outcomes, but obvious evidence for this association is lacking. We investigated the association between PPI use and adverse renal outcomes in patients who had undergone percutaneous coronary intervention.

methodsOf the 1,284 patients hospitalized for percutaneous coronary intervention between January 2007 and May 2012, 934 patients with baseline estimated glomerular filtration rate greater than 60 mL/min/1.73 m

resultsIn adjusted time-dependent Cox models, PPI use was associated with acute kidney injury (hazard ratio [HR], 1.46; 95% confidence interval [95% CI], 1.05-2.02), especially in patients aged 65 years or younger (HR, 2.08; 95% CI, 1.09 3.96) or in patients with diabetes (HR, 2.00; 95% CI, 1.23-3.25). In multivariable Cox models, the association between duration of PPI use and chronic kidney disease development was not statistically significant (HR of heavy users, 1.50; 95% CI, 0.61-3.67), but a longer duration of PPI use was associated with mild renal progression in patients younger than 65 years (HR of heavy users, 2.24; 95% CI, 1.09-4.60).

conclusionOur results suggest that PPI use increases the risk of AKI development, and that PPI use is more significantly associated with acute and chronic renal injuries in younger patients.

Indexed as

Acute kidney injuryChronic kidney failureProton pump inhibitorsRisk factors

Identifiers

PMID29629278
PMCPMC5875577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.